ELAN Elanco Animal Health Incorporated
Elanco Animal Health Incorporated (ELAN) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 20, 2026 , by Kurzius Lawrence Erik .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director | Buy | 40,000 | $23.40 | $935.9K | 188,647 | |
| O'Neill Shiv | GC AND CORP SEC | Buy | 3,998 | $23.58 | $94.3K | 87,832 | |
| Harrington Michael J | Director | Buy | 5,000 | $21.82 | $109.1K | 131,451 | |
| Herendeen Paul | Director | Buy | 10,000 | $23.68 | $236.9K | 111,687 | |
| VanHimbergen Robert M | EVP and CFO | Buy | 4,200 | $23.08 | $96.9K | 137,516 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.